Previous 10 | Next 10 |
Investing in stocks can make you rich. Just how rich and just how quickly you become wealthy varies considerably, of course. The important thing is to pick the right stocks that give you the best shot at delivering exceptional returns over a period of at least 10 years. Three stocks that I...
So far, 2019's been a pretty good year for healthcare stocks in general, but a few younger members of the sector have fallen recently. Shares of Guardant Health (NASDAQ: GH) , Livongo Health (NASDAQ: LVGO) , and Masimo (NASDAQ: MASI) have outperformed in the past, but not in recen...
Thanks to a handful of initial public offerings (IPOs) in the last year, individual investors can now own liquid biopsy stocks. Thanks to awful performance last month, most of them are trading at their lowest levels in months -- or ever. Shares of Adaptive Biotechnologies (NASDAQ: ADPT) f...
Investors should be cautious when a business relies too heavily on a single customer. If the relationship changes or ends, then it's usually not very fun to be a shareholder. It can take years for the company and stock to recover -- if a recovery can be achieved at all. That's what makes the hi...
BARCELONA, Spain, Sept. 28, 2019 (GLOBE NEWSWIRE) -- Guardant Health and the National Cancer Center Hospital East will present data at the European Society of Medical Oncology (ESMO) conference from a prospective, multi-center phase II clinical trial (TRIUMPH). Study showed that patients wi...
Venture capitalists have a simple method for determining whether to invest in a young SaaS start-up or to pass on the opportunity. Dubbed the Rule of 40, this calculation is a way of measuring revenue and profit growth in software companies (even if there are no profits yet). The math is eas...
You might be reluctant to consider investing in healthcare stocks in the current climate. Politicians in Washington are talking about drug pricing reform. Presidential candidates are proposing massive changes to the U.S. healthcare system. There are worries that a recession could be on the way...
Any analyst worth their salt will warn investors that nothing changes quickly in healthcare. Of course, the old axiom doesn't apply to the prices investors will pay for promising new healthcare stocks. These three healthcare stocks made their first appearance on the Nasdaq exchan...
DNA's structure wasn't discovered until 1953. The human genome -- the complete set of DNA sequences in the human body -- wasn't fully sequenced until 50 years later. Fast-forward to today, and we're still only in the early stages of genetic research. Several companies are already generating sig...
High-growth stocks often capitalize on emerging trends and new technologies. But with a world of fast-evolving tech out there, it can sometimes be tricky to identify likely growth stocks . One way to do it, though, is to look at emerging trends and see what companies are likely to benefit. ...
News, Short Squeeze, Breakout and More Instantly...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the company’s ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the first quarter 2024 after market close on Thursday, May 9, 2024. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / ...
New research demonstrates value of epigenomic analysis and methylation sequencing with Guardant liquid biopsy portfolio across continuum of cancer care New data show strong performance of Guardant Reveal™ in detection and quantification of residual disease in early-stage breast can...